Home Fund managers

fund managers

American pensions back Laguna Bay’s eight-farm dairy deal in Tasmania

The firm's debut ag fund encountered few hurdles when bringing in foreign money but its CEO says fresh regulation could now make such transactions more difficult.

Flurry of inexperienced investors ‘creates opportunity’ in Australian agriculture

Laguna Bay Pastoral Company boss Tim McGavin says the firm will probably launch a successor vehicle to its A$280m Australia and New Zealand-focused fund 'in the next year or so.'

New Forests hits full deployment on A$707m antipodean fund

The trans-Tasman manager has sealed the two final deals funded through the vehicle by purchasing two assets from The Rohatyn Group.

Blue Sky buys $30m of water entitlements from Harvard Endowment

Interim MD Kim Morison says the acquisition of the Murrumbidgee tranche is ‘business as usual' for the under-fire Australian asset manager.

Growth Farms secures A$10m cornerstone pledge for new Australia lease fund

The A$100m vehicle has also received significant interest from two overseas investors and a flood of solicitations from potential tenants, its managing director tells Agri Investor.

First State Super CEO: Blue Sky investments have ‘outperformed expectations’

The Australian superfunds’ retiring CEO has said it is ‘comfortable and satisfied’ with its investments with the troubled asset manager.

Blue Sky launches business review and further boardroom changes

The asset manager's share price continued to fall today, falling below the short-seller's target of A$2.66.

Blue Sky’s new MD: ‘Our LPs probably understand our business better than our shareholders’

In an interview with Agri Investor, interim managing director Kim Morison said Robert Shand’s decision to step down was a mutual one between himself and the board.

Blue Sky MD resigns as share price continues to slide

The Brisbane-headquartered asset manager has made multiple changes to its board as Kim Morison steps up to interim managing director.

Blue Sky shares tumble amid renewed Glaucus assault

US short-seller resumes its attack in response to Blue Sky’s rebuttal of its initial research.

Copyright PEI Media

Not for publication, email or dissemination